Literature DB >> 28941532

Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1.

Shannon Jeanine Beres1, Robert A Avery2.   

Abstract

Children with neurofibromatosis type 1 frequently manifest optic pathway gliomas-low-grade gliomas intrinsic to the visual pathway. This review describes the molecular and genetic mechanisms driving optic pathway gliomas as well as the clinical symptoms of this relatively common genetic condition. Recommendations for clinical management and descriptions of the newest imaging techniques are discussed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28941532     DOI： 10.1016/j.spen.2017.04.006

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN： 1071-9091            Impact factor:   1.636


  5 in total

Review 1.  Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1.

Authors:  Felice D'Arco; Sinead Culleton; Laurens J L De Cocker; Kshitij Mankad; Jorge Davila; Benita Tamrazi
Journal:  Pediatr Radiol       Date:  2018-07-06

2.  68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma.

Authors:  Jingjing Zhang; Yongji Tian; Deling Li; Gang Niu; Lixin Lang; Fang Li; Yuhan Liu; Zhaohui Zhu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-03       Impact factor: 9.236

3.  Optic Nerve Gliomas.

Authors:  Edward J Wladis; Matthew A Adamo; Lauren Weintraub
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-19

Review 4.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

5.  Comparison of Visual Acuity Results Between ATS-HOTV and E-ETDRS Testing Methods in Children With Optic Pathway Gliomas.

Authors:  Robert A Avery; Cammille Go; Michael J Fisher; Grant T Liu; Arielle Garcia; Meg Richter; Brendan McGeehan; Graham E Quinn; Gui-Shuang Ying
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.